The Lancet

The Lancet

Book and Periodical Publishing

The best science for better lives

About us

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.

Website
http://www.thelancet.com
Industry
Book and Periodical Publishing
Company size
201-500 employees
Headquarters
London
Type
Public Company
Founded
1823
Specialties
publishing

Locations

Employees at The Lancet

Updates

  • View organization page for The Lancet, graphic

    134,012 followers

    An “impending calamity” that lacks resonance and action. This is how authors of a new report have described the antimicrobial resistance (AMR) issue. 📄 Two years ago, The Lancet published a study estimating AMR was directly responsible for 1.27 million deaths in 2019, mostly in low- and middle-income countries. While dozens of countries around the world have established national plans on AMR, funds and action are lacking. “AMR is not yet a subject that resonates with the average member of the public and this, in turn, influences how much time politicians are willing to invest in the issue”, says Scott Weeze, Professor at the University of Guelph and member of the Global Leaders Group (GLG) on Antimicrobial Resistance. 🗣️ Some fault communication. “The language we are using is not connecting with people”, argues Professor Otto Cars, Uppsala University, Sweden. He continues: “Instead of focusing on terms like ‘AMR’ or the names of bacteria and antibiotics, we should be talking about the diseases that are going to become untreatable—most people know what pneumonia is.” With concerning projections—by 2035, the cost to health care of treating antibiotic-resistant infections could reach US$412 billion per year—motivating public and political engagement is paramount. There are hopes that the new report and September’s second UN General Assembly high-level meeting on AMR will do just that. Read more from Talha Burki ▶️ https://hubs.li/Q02v14rb0 Image credit: putilich from Getty Images via Canva

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    134,012 followers

    Misinformation is not a new phenomenon – far from it. However, the COVID-19 pandemic highlighted how infodemics (an overabundance of information, including mis- and disinformation) pose a threat to health and confidence in research. Two new papers—one in The Lancet Public Health, the other in The Lancet Infectious Diseases—hone in on: 1️⃣ Addressing infodemics through the preventive lens of public health 2️⃣ The social histories of misinformation and infodemics across four pandemic case studies “The spread of health misinformation has always been a public health challenge that has necessitated innovative solutions from medical and public health communities”, write Sabrina L Jin and colleagues. Find links to both papers in the comments section👇 Figure: Public health prevention framework for managing information ecosystems

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    134,012 followers

    In recent decades, advances in breast cancer research and treatment have led to a 40% fall in breast cancer deaths in some high-income countries. However, the burden of breast cancer still looms large worldwide. Join us tomorrow as we launch a new Lancet Commission, with recommendations to address key challenges in breast cancer. Register now ⬇ bit.ly/3x2EDaE

    View organization page for The Lancet, graphic

    134,012 followers

    Save the date for a new Lancet Commission launch 📅 Recent advancements in breast cancer research and treatment have led to a decrease in related deaths of more than 40% in some high-income countries. However, the burden of breast cancer still looms large worldwide. Gross inequities, coupled with the hidden costs of breast cancer, mean that many women and some men are being left behind and forgotten. This is a global blunder. On April 16, hear authors, special guests, and Lancet editors discuss key findings and recommendations from the Commission report. ⬇ Register: bit.ly/3x2EDaE

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • The Lancet reposted this

    View organization page for Elsevier, graphic

    669,622 followers

    Cell Press and The Lancet invite you to a free virtual panel examining #neurodiversity within the scientific community. Through a series of engaging presentations and a live Q&A, this event will feature insights from leading experts. Panelists Mary Doherty (University College Dublin), Hari Srinivasan (Vanderbilt University) and Axelle Ahanhanzo (LAUDACE) will offer insights into making spaces safer for neurodivergent people, discuss intersectionality and neurodivergence, and unpack the importance of evolving scientific language to reflect lived experiences while ensuring rigorous scientific investigation. Gain a deeper understanding of the value of neurodiversity in propelling scientific progress. Register today: https://lnkd.in/eMyh9dZe #science #innovation #research

  • View organization page for The Lancet, graphic

    134,012 followers

    🆕 Prostate cancer cases are projected to double to 2.9 million per year by 2040. In a new Commission report, authors outline evidence-based interventions—such as improved early detection and education programmes—to help save lives and prevent related ill health in the years to come. “As more and more men around the world live to middle and old age, there will be an inevitable rise in the number of prostate cancer cases [...] we need to start planning and take action now”, says Prof. Nick James, co-author. Find out more: https://hubs.li/Q02s4q0Y0 👇 Figure 1: Overview of prostate cancer staging and biology

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    134,012 followers

    Air pollution exposure and cardiometabolic risk – what does the evidence suggest? A recent Global Burden of Disease study estimated that a fifth of worldwide type 2 diabetes is attributable to chronic fine particulate matter (PM2.5) exposure. "Air pollution is by far the most dominant environmental risk factor for health in general, and is responsible for over 9 million annual deaths globally", write authors of a new Review in The Lancet Diabetes & Endocrinology. With 99% of the world's population residing in areas where air pollution levels are above current WHO air quality guidelines, there is a compelling need to better understand the connection between air pollution and cardiometabolic disease, and pathways to address this preventable risk factor. Explore an up-to-date summary of evidence alongside policy interventions ▶️ https://hubs.li/Q02rSYWr0 👇 Figure: Mechanisms of PM2.5-mediated metabolic and cardiovascular effects

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    134,012 followers

    Health and human rights—their relationship is close, and both have come under threat in the last two decades. Seventy-five years after the United Nations’ historic ratification of the Universal Declaration of Human Rights, a new International AIDS Society-Lancet Commission outlines recommendations aimed at reversing concerning trends. In the Commission report, eight domains are explored: 1⃣ Pandemics 2⃣ Climate change 3⃣ Displacement 4⃣ Systemic discrimination 5⃣ Sexual and reproductive health 6⃣ Mis- and disinformation 7⃣ Artificial intelligence 8⃣ Economic and commercial determinants of health “The health and human rights paradigm is uncertain [...] We have articulated the legal, policy, and programmatic changes needed,” say authors. 📄 Access all findings and recommendations: https://hubs.li/Q02qHV3-0 👇 Figure: A socioecological model for health and human rights

    • No alternative text description for this image
  • View organization page for The Lancet, graphic

    134,012 followers

    Save the date for a new Lancet Commission launch 📅 Recent advancements in breast cancer research and treatment have led to a decrease in related deaths of more than 40% in some high-income countries. However, the burden of breast cancer still looms large worldwide. Gross inequities, coupled with the hidden costs of breast cancer, mean that many women and some men are being left behind and forgotten. This is a global blunder. On April 16, hear authors, special guests, and Lancet editors discuss key findings and recommendations from the Commission report. ⬇ Register: bit.ly/3x2EDaE

    This content isn’t available here

    Access this content and more in the LinkedIn app

Similar pages

Browse jobs